Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Information to shareholders: statutory migration

13 Oct 2025 15:30

RNS Number : 1582D
B&M European Value Retail S.A.
13 October 2025
Β 

B&M European Value Retail S.A.

3, rue Gabriel Lippmann, L-5365 Munsbach,

Luxembourg.

Β 

13 October 2025

Β 

Information to shareholders in relation to Shareholding and Settlement Arrangements post Migration

B&M European Value Retail S.A. ("B&M Luxembourg" or the "Company") is pleased to provide further information to shareholders regarding the statutory Migration pursuant to which it will become, in law, B&M European Value Retail plc ("B&M Jersey"), a public limited company governed by the laws of Jersey and will cease to be a sociΓ©tΓ© anonyme ("S.A.") incorporated under the Laws of Luxembourg.Β 

Position regarding shareholdings prior to and following the Migration

Currently, the majority of the shareholders hold their shares either in the form of CREST Depository Interests ("CDIs") or indirectly through a broker, nominee or other custodian account with Euroclear. It is expected that the vast majority of the Company's existing shareholders will not need to take any action as a consequence of the Migration and that they will be able to continue to hold their interest in the Company's shares and to receive dividends in the same way as they do at the moment.

Dividend Mandates

Existing dividend mandates in respect of B&M Luxembourg shares will continue to be effective in relation to shares in B&M Jersey for all existing shareholders provided that any shareholders holding through CREST have enabled their CREST memorandum account to accept dividend payments via the CREST system in relation to their holdings.

Where can you find further information?

The Company has prepared an FAQ document for shareholders, which is available on the Company's website. Shareholders are advised to read the FAQ Document carefully to ensure that they understand the arrangements that will apply to them following the Migration being completed and the actions, if any, that they may wish to take.

Further updates on the Migration process

In anticipation of the Migration, an application will be made for admission of the B&M Jersey shares to the equity shares (commercial companies) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange ("LSE") in place of the B&M Luxembourg shares, upon completion of the Migration (together, the "Admission"). Subject to certain regulatory approvals, it is expected that Admission and unconditional dealings in B&M Jersey shares will become effective after the publication of B&M Luxembourg's interim results on 13 November 2025 and prior to the end of this calendar year.

A new International Securities Identification Number ("ISIN"), JE00BVSYJW51, has been issued in respect of the B&M Jersey shares and will become effective upon the Migration being completed and Admission becoming effective.

A prospectus relating to the Admission is expected to be published by the Company shortly before Admission becomes effective. An announcement will be made at the relevant time via the LSE Regulatory News Service ("RNS") notifying shareholders that the prospectus has been published and that a copy of it is available for inspection on the Company's website.

Disclaimer and Important Information

The information set out in this announcement is for informational purposes only and is not, and is not to be construed as being, legal, business, financial or tax advice. If you are in any doubt the contents of this announcement or the action you should take or any potential tax consequences relating to any changes in the way in which you hold your Shares, you should consult your own appropriately authorised legal adviser, financial adviser or tax adviser.

If you hold your shares through a nominee, broker, custodian, trustee or in an ISA then you should also consult the relevant nominee, broker, custodian, trustee or ISA provider for assistance.

Enquiries

Β 

B&M European Value Retail S.A.

For further information please contact: +44 (0) 151 728 5400

Alexander Simpson

Group General Counsel

Β 

Andrew Orchard

Head of Investor RelationsΒ 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUOASRVOURAAA
Date   Source Headline
20th Aug 20259:00 amRNSDirector/PDMR Shareholding
14th Aug 20255:30 pmRNSDirector/PDMR Exercise of Share Options
1st Aug 202510:00 amRNSDirector/PDMR Shareholding
30th Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jul 20259:01 amRNSResult of EGM
23rd Jul 20259:00 amRNSResult of AGM 22 July 2025
22nd Jul 20254:00 pmRNSTR1 Major Shareholdings in Company
21st Jul 20258:00 amRNSBlock Listing Application
16th Jul 20256:00 pmRNSTR1: Major Shareholding Notification
15th Jul 20257:00 amRNSPositive Quarterly LFL Trading Performance
14th Jul 20255:30 pmRNSBlock Listing Six Monthly Return
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
27th Jun 202511:00 amRNSTR1: Major Holdings in Company
24th Jun 202510:00 amRNSNotice of FY26 Q1 Trading Statement
19th Jun 20254:30 pmRNSDirector Purchase of Shares
19th Jun 20257:00 amRNSNotice of EGM to approve Migration
19th Jun 20257:00 amRNSPublication of Annual Report and Notice of AGM
17th Jun 20257:00 amRNSCEO Purchase of Shares
12th Jun 20255:00 pmRNSDirector/PDMR Purchase of Shares
12th Jun 202510:30 amRNSDirector Share Options
4th Jun 20257:00 amRNSFY25 Preliminary Results
2nd Jun 20256:24 pmRNSTotal Voting Rights
19th May 20255:30 pmRNSTR1: Major Holdings in Company
15th May 20257:00 amRNSAppointment of Tjeerd Jegen as CEO
30th Apr 20257:00 amRNSDirectorate Change
15th Apr 20257:00 amRNSFY25 Post Close Trading Statement
11th Apr 20259:00 amRNSTR1- Major Shareholding Notification
8th Apr 202511:15 amRNSTR1- Major Shareholding Notification
3rd Apr 20256:15 pmRNSTotal Voting Rights - Correction
1st Apr 202512:30 pmRNSTotal Voting Rights
27th Mar 20254:00 pmRNSTR1 - Major Shareholding Notification
24th Mar 202512:00 pmRNSNotice of FY25 Post Close Trading Statement
27th Feb 20257:45 amRNSDirector/PDMR Purchase of Shares
24th Feb 20257:00 amRNSDirectorate Change and Update on FY25 Guidance
19th Feb 20259:00 amRNSTR1 Major Shareholding Notification
7th Feb 20259:00 amRNSTR1 Major Shareholding Notification
3rd Feb 20255:00 pmRNSTR1 Major Shareholding Notification
30th Jan 20255:30 pmRNSTR1 Major Shareholding Notification
24th Jan 202511:00 amRNSTR1 Major Shareholding Notification
20th Jan 202510:45 amRNSResult of OGM
14th Jan 20255:33 pmRNSBlock Listing Six Monthly Return
13th Jan 20254:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS3rd Quarter Trading Update
18th Dec 20248:31 amRNSNotice of Ordinary General Meeting
17th Dec 20249:15 amRNSBoard Appointment
10th Dec 202410:30 amRNSTiming of Announcement of Q3 Trading Statement
9th Dec 20244:00 pmRNSDirector Purchase of Shares
22nd Nov 20244:02 pmRNSDirector Exercise of Share Options
22nd Nov 20244:00 pmRNSDirector Purchase of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.